Allotment of Equity Shares and Convertible warrants on a preferential basis

29th August, 2026 The General Manager BSE Limited, 1st Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001. Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in relation to the allotment of 31,37,586 equity shares and 21,45,145 convertible warrants on a preferential basis. Ref: Intimation dated 02nd July, 2026 and disclosure dated 22nd August, 2026 issued by Parmax Pharma Limited (the “Company”). Dear Sir/ Mam, We refer to the above-mentioned intimation and disclosure made by the Company in connection with the preferential issue of: (i) 31,37,586 equity shares; and (ii) 21,45,145 convertible warrants., we hereby inform you that the Board of directors of the Company, at their meeting held on today, i.e. 29th August inter alia, approved the following: 1. Allotment of 31,37,586 fully paid-up equity shares of the Company at face value of Rs.10 - (Rupee ten only) each to the members of the non-promoter category, on a preferential basis. 2. Allotment of 21,45,145 convertible warrants by way of a preferential issue on a private placement basis to a person belonging to the non-promoter category, convertible into one equity share of fully paid equity shares of the Company having face value of Rs.10/- (Rupees ten only) each, in one or more tranches within a period of 18 months from the date of allotment of convertible warrants. The Company has received the in-principal approval from the Stock Exchange on 21st August, 2026, for issue of the aforesaid specified securities on preferential basis. The meeting of the Board commenced at 3.30 p.m. and concluded at 4.00 p.m. Brief details in accordance with Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are enclosed as Annexure I & Annexure The above information is also available on the website of the company at www.parmaxpharma.com This is for your information and dissemination to the members of the exchange. Thanking You. Yours sincerely, For Parmax Pharma Limited Umang Gosalia Managing Director DIN: 05153830 Encl. Annexure I & II ANNEXURE: I Disclosure in terms of Regulation 30 of the Listing Regulations, read with SEBI Circular on Preferential Issue S.no. Particulars Details Type of securities proposed to be issued Fully paid-up equity shares of the Company. (viz., equity shares, convertibles, etc.) Type of issuance (further public offering, Preferential allotment rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment, etc.) Total number of securities proposed to be The Company allotted 31,37,586 (Thirty one issued or the total amount for which the lakh thirty seven thousand five hundred and securities will be issued (approximately) eighty six) fully paid-up equity shares having a face value of Rs. 10/- each at an issue price of ₹36.50 (Rupees Thirty six point five zero) per Subscription Share which includes a premium of ₹ 26.50 (Rupees Twenty-six point five zero) 3. per equity share aggregating to Rs. 11,45,21,889 (Rupees Eleven Crore Forty-Five Lakh Twenty- One Thousand Eight Hundred Eighty-Nine crores only) to the Non-Promoter Group Category. The Equity shares allotted shall rank pari-passu with the existing equity shares of the Company. 4. Additional Information in case of Preferential Issue: a. Name of the Proposed Allottees Post allotment of securities - outcome of List Enclosed as Annexure-1 A the subscription Issue Price / allotted price (in case of ₹ 36.50 (Rupees Thirty six point five zero) per convertibles), Subscription Share which includes a premium of ₹ 26.50 (Rupees Twenty-six point five zero) per equity share d. Number of Proposed Allottees 14 (Fourteen) In case of convertibles - intimation on e. conversion of securities or on lapse of the Not Applicable tenure of the instrument; Any cancellation or termination of the Not Applicable 5. proposal for the issuance of securities including reasons thereof. ANNEXURE: II Disclosure in terms of Regulation 30 of the Listing Regulations, read with SEBI Circular on Preferential Issue S.no. Particulars Details Fully Convertible warrants each convertible Type of securities proposed to be issued 1. into an equivalent number of fully paid-up (viz., equity shares, convertibles, etc.) equity shares of the Company. Type of issuance (further public offering, rights issue, depository receipts 2. Preferential allotment (ADR/GDR), qualified institutions placement, preferential allotment, etc.) 21,45,145 (Twenty one lakhs forty five Total number of securities proposed to thousand one hundred and forty five) warrants, be issued or the total amount for which convertible into an equivalent number of fully the securities will be issued paid-up equity shares having a face value of (approximately) Rs. 10/- each at a price of Rs. 36.50/- per warrant to Non-Promoter Category. 4. Additional Information in case of Preferential Warrants Issue: a. Name of the Proposed Warrants Allottees Post allotment of securities - outcome of List Enclosed as Annexure-1 A the subscription ₹ 36.50 (Rupees Thirty-six point five zero) which includes a premium of ₹ 26.50 (Rupees Issue price / allotted price (in case of Twenty-six point five zero) per warrant (i.e. convertibles), warrant exercise price), as per the provisions of Regulation 164 of Chapter V of the SEBI ICDR Regulations. d. Number of Proposed Warrants Allottees 13 (Thirteen) Each warrant will be convertible into 1 equity share of Rs. 10/- each and the rights attached to the warrants can be exercised in one or more tranches at any time within the period of 18 In case of convertibles - intimation on (eighteen) months from the date of allotment e. conversion of securities or on lapse of of the warrants, subject to other terms and the tenure of the instrument; conditions as applicable. The Equity shares to be allotted upon conversion of warrants shall rank pari passu with the existing equity shares of the Company. Any cancellation or termination of the Not Applicable 5. proposal for the issuance of securities including reasons thereof. List Enclosed as Annexure-1 A Pre- No. of Post-Issue % of Post No. of Proposed Issue % of Pre Warrants Holding Preferential Name of the Equity status / Holding Preferential allotted (No. of Issue of Sr. Allottees/ Current Status / Shares / Category (No. of Issue Capital (D) Equity Equity No. Warrants Category Subscription of the Equity (% of A) Shares) Shares Allottees Shares Allottees Shares) 2026 (B) (E)*^ (% of E) allotted (C) Dhiren Non-Promoter 1. Chandulal (Public) Promoter 0.00 0.00 604,190 535,715 11,39,905 12.63 Shah Sunil Non-Promoter 2. Chinubhai (Public) Promoter 0.00 0.00 91,911 81,494 1,73,405 1.92 Shah Hiren Pravin Non-Promoter 3. Promoter 0.00 0.00 217,508 192,857 410,365 4.55 Doshi (Public) Umang Non-Promoter 4. Alkesh (Public) Promoter 200,000 5.35 342,466 -- 542,466 6.01 Gosalia Sheetal Hiren Non-Promoter Promoter 5. 0.00 0.00 24,167 21,429 45,596 0.51 Doshi (Public) Group Nirmal Non-Promoter Promoter 6. Sunilbhai (Public) 32,500 0.87 164,832 144,715 342,047 3.79 Group Shah Dhairya Non-Promoter Promoter 7. 0.00 0.00 120,838 107,143 227,981 2.53 Dhiren Shah (Public) Group Rupa Sunil Non-Promoter Promoter 8. 0.00 0.00 69,206 61,363 130,569 1.45 Shah (Public) Group Vijaykumar Non-Promoter Promoter 9. Natvarlal (Public) 0.00 0.00 161,117 142,857 303,974 3.37 Group Shiyani Kamlesh Non-Promoter Promoter 10. Natvarlal (Public) 7,500 0.20 161,974 143,286 312,760 3.47 Group Shiyani Abhay Non-Promoter Promoter 11. Chinubhai (Public) 0.00 0.00 322,235 285,715 607,950 6.74 Group Shah Urvi Manish Non-Promoter Non- 12. Kothari (Public) Promoter 0.00 0.00 285,714 142,857 428,571 4.75 (Public) Mili Saumil Non-Promoter Non- 13. Shah (Public) Promoter 0.00 0.00 285,714 142,857 428,571 4.75 (Public) Fredun Non-Promoter Non- Nariman (Public) Promoter 14. 0.00 0.00 285,714 142,857 428,571 4.75 Medhora (Public) [Showing first 8,000 characters — download PDF for full document]